Alexandria, VA – May 1, 2024 – The Innovation and Value Initiative (IVI), a non-profit research organization committed to advancing the science, practice, and use of health technology assessment (HTA) in healthcare, today announced its participation at ISPOR 2024, May 5-8, 2024, at the Georgia World Congress Center in Atlanta. IVI will present six posters throughout the event.
IVI executives Jason Spangler, MD, MPH, FACM, Chief Executive Officer; Rick Chapman, PhD, Chief Science Officer; Larragem Raines, MS, Director of Research; among other staff will attend in person. They will participate in workshops and poster presentations during the conference, where the most dynamic thought leaders in health equity and HTA discuss today’s hottest trends and topics.
They look forward to continuing the conversation with their peers and collaborators during the conference. Anyone who is interested in meeting in person and learning about IVI’s work is encouraged to reach out.
- Monday, May 6 (11:30 AM – 12:15 PM): Poster Session 1, “Incorporating Stakeholder Perspectives into Open-Source Model Building for Major Depressive Disorder” (Presenting Author: Larragem Raines, MS, Innovation and Value Initiative)
- Monday, May 6 (11:30 AM – 12:15 PM): Poster Session 7, “Engaging Patients with Rare Disease in Identifying Meaningful Approaches to Integrate Patient-Centered Outcomes in Comparative Effectiveness Research and Value Assessment” (Presenting Author: Michelle Cheng, MHS, Innovation and Value Initiative)
- Monday, May 6 (10:30 AM – 1:30 PM): Poster Session 1, “Exploring Frameworks and Methodology to Incorporate Equity in Health Economics Evaluation: A Scoping Review” (Presenting Author: Tim Lai)
- Tuesday, May 7 (3:30 PM – 6:30 PM): Poster Session 4, “Advancing Patient-Centered Outcomes Research for Rare Diseases: A Mixed-Methods Approach” (Presenting Author: Michelle Cheng, MHS, Innovation and Value Initiative)
- Wednesday, May 8 (9:00 AM – 11:30 AM): Poster Session 5, “Estimating the Impact of Delayed Treatment for Major Depressive Disoder Using a Continuous-Time Patient-Level Simulation Model” (Presenting Authors: Michelle Cheng, MHS, Innovation and Value Initiative and Richard Chapman, PhD, Innovation and Value Initiative)
- Wednesday, May 8 (9:00 AM – 11:30 AM): Poster Session 5, “No Value Without Equity: Transforming Power, People, and Processes for Equity in Health Technology Assessment” (Presenting Author: Richard Chapman, PhD, Innovation and Value Initiative).
Click here for a full list and details of all IVI ISPOR presentations.
###
About IVI
The Innovation and Value Initiative (IVI) is a 501(c)(3) tax-exempt non-profit research organization dedicated to advancing the science and improving the practice of health technology assessment through development of novel methods and the creation and application of enhanced health technology assessment models to support local decision-making needs in healthcare.
Contact: Smita Sanwardeker, (267) 909-7661, smita.sanwardeker@thevalueinitiative.org.
